Pharmaceuticals by days to cover

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

AstraZeneca has the lowest figure of the 61 pharmaceuticals ranked by days to cover, at 0.9, followed by Takeda Pharmaceutical (1.0) and Genmab (1.2). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report.

Key facts

Companies ranked
61
Lowest
AstraZeneca0.9
Median
5.3
Combined market value
$5.13T
Countries
10

Market values as of .

Pharmaceuticals by days to cover
#CompanyDays to cover ↑Market capPriceToday1 yearPrice, 30 daysCountry
1AstraZenecaAZN · Health Care0.9$279.8B$180.41 1.02% down 2% up United Kingdom
2Takeda PharmaceuticalTAK · Health Care1.0$68.7B$21.51 0.60% down 54% up Japan
3GenmabGMAB · Health Care1.2$31.9B$51.70 0.50% down 70% up Denmark
4NovartisNVS · Health Care1.9$297.1B$157.30 1.15% down 25% up Switzerland
5Alnylam PharmaceuticalsALNY · Health Care1.9$20.9B$156.02 0.31% down 66% down United States
6Abbott LaboratoriesABT · Health Care1.9$181.6B$104.87 0.15% up 17% down United States
7Merck & CoMRK · Health Care2.4$348.9B$141.52 1.29% down 51% up United States
8Johnson & JohnsonJNJ · Health Care2.4$667.1B$277.13 0.56% down 38% up United States
9Eli LillyLLY · Health Care2.7$1.25T$1,401.70 0.98% down 35% up United States
10Regeneron PharmaceuticalsREGN · Health Care2.7$99.5B$961.78 0.42% up 36% up United States
11Amneal PharmaceuticalsAMRX · Health Care2.8$7.5B$21.52 1.89% up 83% up United States
12SanofiSNY · Health Care2.8$114.2B$47.56 0.06% up 4% down France
13GSKGSK · Health Care3.2$98.5B$49.15 0.18% down 6% up United Kingdom
14AbbVieABBV · Health Care3.3$514.3B$290.98 0.63% down 26% up United States
15Axsome TherapeuticsAXSM · Health Care3.3$7.1B$135.00 0.70% down 7% down United States
16Vertex PharmaceuticalsVRTX · Health Care3.4$137.2B$541.30 1.33% up 27% up United States
17United TherapeuticsUTHR · Health Care3.5$24.7B$580.40 0.63% down 23% up United States
18InsmedINSM · Health Care3.6$26.7B$121.93 0.06% up 40% down United States
19Kiniksa Pharmaceuticals InternationalKNSA · Health Care3.9$7.6B$96.61 1.58% up 126% up United Kingdom
20Royalty PharmaRPRX · Health Care4.0$39.6B$68.88 0.29% up 78% up United States
21ViatrisVTRS · Health Care4.0$23.7B$20.70 1.20% up 96% up United States
22Novo NordiskNVO · Health Care4.0$177.1B$40.19 1.25% down 17% down Denmark
23Bristol-Myers SquibbBMY · Health Care4.2$124B$60.67 1.12% down 34% up United States
24BeOne MedicinesONC · Health Care4.4$46.4B$406.38 1.67% down 17% up Switzerland
25PfizerPFE · Health Care4.6$161.3B$28.31 0.58% down 14% up United States
26ABIVAXABVX · Health Care4.6$7.4B$83.97 2.27% up 27% down France
27Travere TherapeuticsTVTX · Health Care4.7$4.9B$50.77 0.64% down 44% up United States
28ZoetisZTS · Health Care4.8$34B$83.74 0.31% up 29% down United States
29Ascendis PharmaASND · Health Care5.0$17.8B$271.25 0.02% up 28% up Denmark
30VeradermicsMANE · Health Care5.1$5.4B$126.82 0.94% up 233% up United States
31Teva Pharmaceutical IndustriesTEVA · Health Care5.3$50B$42.87 0.59% up 74% up Israel
32BioMarin PharmaceuticalBMRN · Health Care5.8$11.5B$59.31 1.37% up 11% up United States
33Definium TherapeuticsDFTX · Health Care5.8$4B$29.55 0.56% up 169% up United States
34Roivant SciencesROIV · Health Care6.1$28.4B$39.14 1.11% up 90% up United Kingdom
35Legend BiotechLEGN · Health Care6.3$3.2B$16.43 1.99% up 42% down United States
36BridgeBio PharmaBBIO · Health Care7.1$15.1B$77.76 1.25% up 17% up United States
37Oruka TherapeuticsORKA · Health Care7.1$6.6B$98.01 1.75% up 241% up United States
38Elanco Animal HealthELAN · Health Care7.2$13.2B$26.32 1.82% up 20% up United States
39PTC TherapeuticsPTCT · Health Care7.5$5.1B$60.62 0.43% up 20% down United States
40Madrigal PharmaceuticalsMDGL · Health Care7.6$9.8B$420.40 0.38% down 24% down United States
41Jazz PharmaceuticalsJAZZ · Health Care7.7$15.6B$242.84 0.88% up 37% up Ireland
42Dr. Reddy's LaboratoriesRDY · Health Care7.8$12.5B$14.98 1.18% up 5% up India
43GrifolsGRFS · Health Care8.1$5.9B$8.60 0.35% down 1% up Spain
44Corcept TherapeuticsCORT · Health Care8.1$7.7B$70.09 0.02% up 8% down United States
45Ionis PharmaceuticalsIONS · Health Care8.4$4.6B$27.39 1.59% up 64% down United States
46Arrowhead PharmaceuticalsARWR · Health Care8.5$6.2B$43.70 1.65% up 10% up United States
47Cogent BiosciencesCOGT · Health Care8.7$4.9B$28.35 1.80% up 20% down United States
48Praxis Precision MedicinesPRAX · Health Care8.7$8.7B$310.91 1.92% up 61% up United States
49ErascaERAS · Health Care8.9$4.8B$13.55 2.48% down 403% up United States
50Summit TherapeuticsSMMT · Health Care9.4$9B$11.30 5.93% up 36% down United States
51Edgewise TherapeuticsEWTX · Health Care9.6$4.6B$41.58 1.11% down 88% up United States
52Belite BioBLTE · Health Care10.0$6.4B$157.94 0.14% up 31% up United States
53Dianthus TherapeuticsDNTH · Health Care10.1$5B$87.97 1.14% up 113% up United States
54Ligand PharmaceuticalsLGND · Health Care10.5$5.9B$296.38 0.87% up 43% up United States
55AlkermesALKS · Health Care11.3$7.8B$46.36 1.99% up 58% up Ireland
56Mirum PharmaceuticalsMIRM · Health Care11.8$6B$92.02 0.07% up 31% up United States
57Spyre TherapeuticsSYRE · Health Care12.7$9.1B$95.98 2.31% up 286% up United States
58CytokineticsCYTK · Health Care14.2$7.3B$52.57 1.78% up 20% down United States
59Protagonist TherapeuticsPTGX · Health Care16.9$8.2B$125.98 1.05% up 46% up United States
60TG TherapeuticsTGTX · Health Care18.9$9.7B$63.94 1.96% up 107% up United States
61Rhythm PharmaceuticalsRYTM · Health Care23.3$8.1B$116.34 0.24% down 13% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. Days to cover is short interest divided by FINRA's average daily volume for the period, worked out here: FINRA's own printed figure is floored at 1 and capped at 999.99, so it is not used. A company with no average volume reported has no days to cover and is not ranked.

Questions and answers

Which pharmaceuticals have the lowest days to cover?

AstraZeneca (0.9), Takeda Pharmaceutical (1.0) and Genmab (1.2) have the lowest days to cover of the 61 pharmaceuticals ranked here as of the 30 Oct 2026 settlement date.

How many pharmaceuticals are in this ranking?

61 are ranked by days to cover.

What are these pharmaceuticals worth together?

The 61 pharmaceuticals ranked by days to cover have a combined market value of $5.13T as of the 30 Oct 2026 settlement date.

What does ranking by days to cover measure?

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

Cite this page

Funkfolio, “Pharmaceuticals by days to cover”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=days-to-cover

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.